Literature DB >> 2294807

Postoperative surveillance of patients with carcinoma of the colon and rectum.

M S Rocklin1, C A Slomski, A L Watne.   

Abstract

The early detection and management of recurrence following curative resection for colorectal carcinoma can prolong survival. However, at the present time there is no consensus on the appropriate follow-up protocol for such patients. This investigation was undertaken to determine which tests and procedures are most useful in detecting recurrence and the frequency with which they should be employed. Another purpose of this study was to identify those patients at high risk for recurrence. Sixty-five patients who underwent curative resection of adenocarcinoma of the colon and rectum were followed for at least two years or until recurrence. Thirty were classified as Duke's A carcinoma of the colon, 18 were Duke's B, and 17 were Duke's C. Mean follow-up was 44.9 months. The follow-up regimen consisted of clinical exam, liver function tests, carcinoembryonic antigen (CEA) level, and chest x-ray every three months for the first two years postoperatively and every six months thereafter, and colonoscopy or barium enema and proctoscopy every six months for the first two years postoperatively and every year thereafter. Seventeen patients (26%) had a recurrence; 24% per cent of these developed within one year, 65 per cent developed within two years, 82 per cent developed within three years, and 94 per cent developed within four years of resection. Recurrence was detected by CEA in eight patients, chest x-ray in five, endoscopy in three, and laparotomy for small-bowel obstruction in one patient.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294807

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  10 in total

Review 1.  Cost-effective management of colon and rectal cancer.

Authors:  J A Heine; D A Rothenberger
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

2.  Routine compared with nonscheduled follow-up of patients with "curative" surgery for colorectal cancer.

Authors:  R Bergamaschi; J P Arnaud
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

3.  Follow up of patients with colorectal cancer: no simple solutions.

Authors:  J M Gollock
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

4.  [Present treatment strategies for rectal carcinoma].

Authors:  T Liersch; C Langer; B M Ghadimi; H Becker
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

5.  Post-treatment management options for patients with lung cancer.

Authors:  K S Virgo; L W McKirgan; M C Caputo; D M Mahurin; L C Chao; N A Caputo; K S Naunheim; M W Flye; K N Gillespie; F E Johnson
Journal:  Ann Surg       Date:  1995-12       Impact factor: 12.969

6.  Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful?

Authors:  G Li Destri; S Greco; C Rinzivillo; A Racalbuto; R Curreri; A Di Cataldo
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Follow-up of patients with colorectal cancer. A meta-analysis.

Authors:  D J Bruinvels; A M Stiggelbout; J Kievit; H C van Houwelingen; J D Habbema; C J van de Velde
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

8.  Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists.

Authors:  K S Virgo; T P Wade; W E Longo; M A Coplin; A M Vernava; F E Johnson
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

Review 9.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10

10.  A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province.

Authors:  Robert J Hilsden; Heather E Bryant; Lloyd R Sutherland; Penny M A Brasher; Anthony L A Fields
Journal:  BMC Cancer       Date:  2004-04-19       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.